Navigation Links
Adamis Pharmaceuticals CEO Provides Update for Shareholders
Date:5/3/2013

ur Beclomethasone-HFA product to initiate Phase III studies in asthma and COPD
  • Finalizing our allergic rhinitis product development in order to initiate Phase III clinical trials
  • Acquiring or in-licensing an established product or technology that, following regulatory marketing approvals, will compete in large (multi-billion dollar) product markets and will be synergistic with our existing assets.
  • On the Biotech side, we are focused on:

    • Completing our Phase I prostate cancer drug trial
    • Finalizing the activities necessary to begin a Phase I/II trial for our second prostate compound
    • Initiating a Phase II prostate cancer vaccine trial for TeloB-VAX.

    If we are able to complete additional financing transactions and make progress on our objectives, we intend to take the necessary steps to be in a position to list our common stock on a national stock exchange such as the NYSE-Amex or NASDAQ.  An up-listing could lead to an increase in shareholder value, give Adamis more market exposure, increase liquidity and partnering activities and increase our shareholder base to include more fundamental health care investors.

    I would like to thank all of our shareholders for their continued support and patience.  We will all do our very best to make Adamis a company that you will all be very proud of owning.

    Best regards,

    Dennis J. Carlo , Ph.D
    President and CEO

    About Adamis Pharmaceuticals Corporation

    Adamis Pharmaceuticals Corporation is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology.  Products in its specialty pharmaceutical pipeline include the Epinephrine Injection PFS syringe for use in the emergency treatment of a
    '/>"/>

    SOURCE Adamis Pharmaceuticals Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
    2. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
    3. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
    4. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
    5. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
    6. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
    7. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
    8. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
    9. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
    10. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
    11. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... August 29, 2014 Pittcon is pleased ... and colleague Koichiro Matsuda, Horiba Scientific, have organized a ... 5, 2014. JASIS , Asia’s largest analytical and ... in Makuhari Messe, Japan. , The four speakers ... Bioanalysis from Single Molecules to Single Cells” will present ...
    (Date:8/29/2014)... (PRWEB) August 29, 2014 Three ... Energy's 2014 Hydrogen Production R&D Award ... by splitting water using sunlight. , Shared with ... and the University of Nevada, Las Vegas (UNLV), ... developing models of photoelectrochemical solar-hydrogen production and corrosion ...
    (Date:8/29/2014)... August 29, 2014 Intrinsic Imaging, ... certified, GAMP® 5 compliant imaging core lab, announced ... Phase II clinical trial to assess a new ... this trial, Intrinsic Imaging will provide comprehensive imaging ... protocol and charter development, site qualification, site training ...
    (Date:8/28/2014)... 2014 Best Sanitizers, Inc., the first ... hand sanitizer, asks food processors and food handling professionals ... sanitizer they’re currently using to Best Sanitizers’ Alpet® ... critical to fighting cross-contamination and the spread of pathogens ... there are key criteria that make a hand sanitizer ...
    Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Livermore Team Awarded for Hydrogen Production Research 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3
    ... Former ... campuses -- San Francisco and Berkeley -- to jointly launch the first program of its ... , ... Former Intel Corp. chief executive Andy Grove has pledged $1.5 million to two University of ...
    ... SAN DIEGO , May 20 Researchers ... research organization, published results today describing the successful construction of ... 1.08 million base pair chromosome of a modified Mycoplasma ... mycoides JCVI-syn1.0 and is the proof of principle that ...
    ... NewLink Genetics Corporation today announced that preliminary data from its Phase 2 ... pancreatic cancer will be presented during a poster session at the American ... 2010 in Chicago, Illinois . A summary of the company,s ... , , ...
    Cached Biology Technology:Grove Gift Launches Translational Medicine Program at UCSF & UC Berkeley 2Grove Gift Launches Translational Medicine Program at UCSF & UC Berkeley 3Grove Gift Launches Translational Medicine Program at UCSF & UC Berkeley 4First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 2First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 3First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 4First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 5First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 6First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers 7NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting 2NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting 3
    (Date:8/28/2014)... available in German . ... its name to a striking pattern of blue stripes alternating ... reflective silvery cells, and yellow cells emerge during growth in ... a multilayered mosaic to compose the characteristic colour pattern. ... have to interact to form proper stripes, the embryonic origin ...
    (Date:8/28/2014)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for the Genetics Society of America,s 27th ... October 3, 2014 in Pacific Grove, California. ... entry of students, post doctorates and scientists from ... science community and to encourage the participation of ...
    (Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) Program ... American College of Sports Medicine,s Conference on Integrative ... Miami, Florida. These awards are meant to ... scientists from underrepresented groups into the mainstream of ... participation of young scientists at the American College ...
    Breaking Biology News(10 mins):How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3
    ... the Gemini North telescope and W.M. Keck Observatory on Hawaii,s ... obtained the first-ever direct images identifying a multi-planet system around ... team to make the initial discovery of two of the ... Oct. 17, 2007. Then, on Oct. 25, 2007, and in ...
    ... in the open ocean may force scientists to rethink their ... A paper describing the new findings appears in the ... A research team led by Jonathan Zehr, a marine scientist ... microbe by analyzing its genetic material, even though researchers have ...
    ... Humana Press journal Neuroinformatics describes the ... of web-based neurosciences data, resources and tools that ... connected to the Internet. An initiative of ... Research, the NIF will advance neuroscience research by ...
    Cached Biology News:Planetary 'first family' discovered by astronomers using Gemini and Keck Observatories 2Mysterious microbe plays important role in ocean ecology 2Mysterious microbe plays important role in ocean ecology 3Neuroinformatics special issue spotlights the Neuroscience Information Framework 2
    ... The AquaMax DW4 liquid handling system from ... washing all in one instrument. The system ... dispensing and plate washing96-, 384- and 1536-welland ... washing. AquaMax DW4 has been optimized to ...
    A univariate (peak height or area) quantitative multi-component analysis package....
    ... a dramatic breakthrough in accurate, small-volume bulk dispensing. ... the micro 1 has unique advantages not found ... 1 never needs re-calibration as do other 1mL ... an LCD Display , Graphical Row Selection , ...
    ... Motic's B3 series of microscopes offer all ... required for laboratory work. Equipped with Koehler ... Contrast (ASC) objectives. The B3 is the ... Siedentopf binocular tube eliminates the need for ...
    Biology Products: